Related Experiment Video
Updated: Dec 18, 2025

Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues
Published on: June 3, 2019
Sestrin 2 controls the cardiovascular aging process via an integrated network of signaling pathways
Yunxia Liu1, Xiaoyu Du1, Zhehao Huang2
1Cardiovascular Center, First Hospital of Jilin University, Changchun, Jilin, 130021, China.
Abstract:
As an inevitable biological process, cardiovascular aging is the greatest risk factor for cardiovascular diseases (CVDs). Sestrin 2 (Sesn2), a stress-inducible and age-related protein associated with various stress conditions, plays a pivotal role in slowing this process. It acts as an anti-aging agent, mainly through its antioxidant enzymatic activity and regulation of antioxidant signaling pathways, as well as by activating adenosine monophosphate-activated protein kinase and inhibiting mammalian target of rapamycin complex 1. In this review, we first introduce the biochemical functions of Sesn2 in the cardiovascular aging process, and describe how Sesn2 expression is regulated under various stress conditions. Next, we emphasize the role of Sesn2 signal transduction in a series of age-related CVDs, including hypertension, myocardial ischemia and reperfusion, atherosclerosis, and heart failure, as well as provide potential mechanisms for the association of Sesn2 with CVDs. Finally, we present the potential therapeutic applications of Sesn2-directed therapy and future prospects.
Insights
Sestrin 2 (Sesn2) protein slows cardiovascular aging and combats age-related cardiovascular diseases through antioxidant and signaling pathway regulation. This review explores Sesn2
Area of Science:
- Biochemistry and Molecular Biology
- Cardiovascular Research
- Aging and Gerontology
Background:
- Cardiovascular aging is a primary risk factor for cardiovascular diseases (CVDs).
- Sestrin 2 (Sesn2) is a stress-inducible protein implicated in mitigating aging processes.
- Sesn2's role in cardiovascular health and disease is increasingly recognized.
Purpose of the Study:
- To review the biochemical functions of Sesn2 in cardiovascular aging.
- To describe Sesn2 expression regulation under stress.
- To emphasize Sesn2's role in age-related CVDs and explore therapeutic potential.
Main Methods:
- Literature review of Sesn2's biochemical functions.
- Analysis of Sesn2 regulation under stress conditions.
- Examination of Sesn2 signaling in age-related cardiovascular diseases.
Main Results:
- Sesn2 exhibits antioxidant activity and regulates antioxidant pathways.
- Sesn2 activates adenosine monophosphate-activated protein kinase (AMPK) and inhibits mTORC1.
- Sesn2 signaling is linked to hypertension, ischemia-reperfusion injury, atherosclerosis, and heart failure.
Conclusions:
- Sesn2 acts as a crucial anti-aging agent in the cardiovascular system.
- Sesn2 plays a significant role in the pathophysiology of various age-related CVDs.
- Targeting Sesn2 presents promising therapeutic strategies for cardiovascular aging and disease.
More Related Videos
Related Concept Videos
Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
Nitric Oxide Signaling Pathway
Hormonal Regulation of Blood Pressure
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Regulation of Heart Rates
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
Hypertension II: Pathophysiology
Regulation of Angiogenesis and Blood Supply

